Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

PAVM - PAVmed Inc.

IEX Last Trade
0.6189
0   0%

Share volume: 5,806
Last Updated: Mon 13 Jan 2025 08:06:28 PM CET
Surgical and Medical Instrument Manufacturing : -0.20%

PREVIOUS CLOSE
CHG
CHG%
$0.62
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
26%
Profitability 43%
Dept financing 32%
Liquidity 22%
Performance 10%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.89%
1 Month
-20.52%
3 Months
-44.75%
6 Months
-35.35%
1 Year
-78.68%
2 Year
-93.08%
Key data
Stock price
$0.62
P/E Ratio 
0.87
DAY RANGE
$0.62 - $0.63
EPS 
-$7.16
52 WEEK RANGE
$0.62 - $3.50
52 WEEK CHANGE
-$78.68
MARKET CAP 
12.800 M
YIELD 
N/A
SHARES OUTSTANDING 
10.406 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$450,622
AVERAGE 30 VOLUME 
$332,662
Company detail
CEO: Lishan Aklog
Region: US
Website: pavmed.com
Employees: 90
IPO year: 2016
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE)

Recent news